Category: BioTech
The analysis published under this category are as follows.Friday, March 15, 2013
How Stock Market Investors Can Ride the Nanotech Revolution / Companies / BioTech
G.S. Early writes: I know that for more than a few of you, as soon as you hear the word "nanotech" your eyes glaze over and you fumble for the mouse.
But don't touch that mouse. Nanotech has come a long way and is becoming one of the most incredible technology stories of the decade, if not the century.
Read full article... Read full article...
Friday, March 08, 2013
10 Biotech Stocks Poised to Run / Companies / BioTech
For the first time in ages, conditions for biotech investment are just right. The capital markets have loosened up, and institutional investors are ready to bid up share prices on stories that have both merit and looming catalysts. Sure, there's risk. . .but without it, there's no upside. In this Life Sciences Report interview, Senior Analyst and Managing Director George Zavoico of MLV & Co. identifies a group of biotech companies with market-moving events on their calendars. Sharpen your pencils: From cancer to coronary artery disease to vaccine technology, Zavoico names potential winners.
Read full article... Read full article...
Sunday, March 03, 2013
Small Companies Hubs of Future Profit in Regenerative Medicine / Companies / BioTech
Gil Van Bokkelen has been in the stem cell industry for more than a decade. In recent years, the co-founder, chairman and chief executive officer of Athersys Inc. has stepped into regenerative medicine’s forefront, acting as a spokesman for the industry as well as demonstrating his love of science and passionately advocating for patients. In this interview with The Life Sciences Report, Van Bokkelen explores the past, present and future of the cell therapy and regenerative medicine industry, and outlines the investment possibilities in small companies on the sector's cutting edge.
Read full article... Read full article...
Friday, March 01, 2013
Biotech Miracle Medical Breakthrough: Printing 3D Organs! / Companies / BioTech
Michael A. Robinson writes: Imagine a future in which anyone needing a transplant could just create the needed tissue on their home printer.
That day hasn't arrived yet ... but it's getting closer all the time.
A partnership between a global software firm and an early-stage biotech player is already promising to transform the field of medical transplants.
Read full article... Read full article...
Wednesday, February 27, 2013
The Picks and Shovels of Biotech Investing / Companies / BioTech
Marc Lichtenfeld writes: Yesterday marked the 184th birthday of an iconic American businessman – Levi Strauss
My wife worked for Levi Strauss & Co. many years ago. They were a terrific company, with a strong commitment to product quality, their employees and their community. I was so impressed that I remain loyal and almost exclusively buy Levi’s when I need a pair of jeans.
Read full article... Read full article...
Wednesday, January 16, 2013
BioTech Bull Market's Next 1,000%-Plus Move Starts Now / Companies / BioTech
Dr. Steve Sjuggerud writes: Biotech stocks have an incredible history of delivering quadruple-digit runs about once a decade...
It's stunning, really. In the late 1980s, biotech stocks took off, returning 3,246% in just a couple years. In the late 1990s, biotech stocks took off again, returning 1,523% in an even shorter period of time.
Thursday, December 13, 2012
The Next Profit Breakthrough: Synthetic Biology / Companies / BioTech
Michael A. Robinson writes: Drug, chemical, and biofuel firms are relying more than ever on artificial fragments of DNA to invent new products. It's called synthetic biology.
For example, teams all over the world are now in their labs looking to create novel biotech compounds or drugs by inserting synthetic DNA into cells, either living or artificial. They're also growing new microorganisms that yield biofuels to be used in lieu of oil.
Read full article... Read full article...
Tuesday, December 11, 2012
Cancer, Breaking Down a Biotech Winner / Companies / BioTech
Traditional cancer treatment options are little more than a crude mix of "slash, burn, and poison" â �that is surgery, radiation, and chemotherapy. There are radical new treatments in labs and trials all over the world that promise to throw out this trifecta; no other disease has received more of the research interest and funding that have defined modern biotechnology over the past three decades.
Read full article... Read full article...
Thursday, November 15, 2012
Biotech Stocks to Buy Now / Companies / BioTech
Don Miller writes: If you're looking to hit a home run over the next 12 months, your best bet for stocks to buy now is biotechnology companies - especially those focused on cancer research.
Here's why: biotech stocks have been in a stealth bull market in 2012.
Read full article... Read full article...
Monday, October 22, 2012
Adult Stem Cells: Investors can Cash in on the New Fountain of Youth / Companies / BioTech
Michael A. Robinson writes: It's flat-out amazing how fast the science of adult stem cells is moving.
Just last week, I told you about two scientists who won the 2012 Nobel Prize in Medicine for creating this field.
Read full article... Read full article...
Friday, October 19, 2012
Adult Stem Cell Miracle Will Generate Investor Profits / Companies / BioTech
Michael A. Robinson writes: Recently, I was in a meeting at our headquarters in Baltimore, explaining to my editor how excited I was to tell readers about a whole new range of adult stem-cell breakthroughs.
This field of medicine is so exciting it was easy to show how these adult stem cell lines will someday play a vital role in the future of the human race.
Read full article... Read full article...
Friday, October 12, 2012
Forecasting Explosive Biotech Growth, Investor Patience / Companies / BioTech
The myth of technology, whether for smartphones or cancer treatments, is that the next big thing appears suddenly and magically. Casey Research Analyst Alex Daley sets the record straight in this exclusive interview with The Life Sciences Report. While the science of genetic medicine has accelerated the process of turning magical thinking into practical medicine, Daley cautions investors in biotech and medical device companies to be patient, and names companies with innovative technologies poised for explosive growth.
The Life Sciences Report: At Casey Research's "Navigating the Politicized Economy" summit, you talked about the difference between the speed of science and the speed of technology, and how quickly the time to market and cost of products in the life sciences space is decreasing. Can you provide some examples?
Read full article... Read full article...
Monday, October 01, 2012
New "Protein Chips" Could Save Your Life and Make You Money / Companies / BioTech
Michael A. Robinson writes: Ever since some wag came up with the term "Silicon Valley" in the 1970s, investors have thought of semiconductors as the brains behind computers.
That was then. This is now...
Today, semiconductors are about a lot more than computers.
Read full article... Read full article...
Friday, August 24, 2012
The Key to Huge Biotech Profits / Companies / BioTech
Chen Lin is a well-known expert junior metals and energy investor, but he has found compelling reasons to diversify into biotechnology. In this exclusive interview with The Life Sciences Report, Lin meshes common sense and personal experience with his trademark brand of aggressive investment savvy to identify three life sciences stocks that could be huge gainers for investors.
The Life Sciences Report: Chen, we know you as a natural resource investor. How long have you been a life sciences investor? Is this a new category for you?
Read full article... Read full article...
Monday, August 20, 2012
These Biotech Firms Will Literally Change the World / Companies / BioTech
Michael A. Robinson writes: The biotech industry is getting ready to transform the human race as we know it.
It will help us cure cancer, rid us of the scourge of Alzheimer's, and make 100-year life spans routine. Not only that, but we will lead much healthier and more intelligent lives as a result.
Read full article... Read full article...
Monday, August 13, 2012
"Bionic Eyes" Could Make Blindness a Thing of the Past / Companies / BioTech
Michael A. Robinson writes: Just last week I told you the day of bionic humans is at hand.
Some of you were excited by the possibilities. Take Matt:
"As someone who has bounced back from a severe head injury 25 years ago to do things the brain injury rehab team told me would simply not be possible - complete my bachelor's degree as well as a master's, get married, and subsequently raise a son on my own as a single parent, etc. - I am especially excited about the possibilities at the juncture of neurological research, computing technology, and prosthetics. I will be overjoyed when the day comes that I can once again use both my hands to type 100 words/minute with few to no mistakes, like I could when I first learned to type on an electric typewriter, nearly 40 years ago."
Read full article... Read full article...
Thursday, July 26, 2012
Man-Made Proteins Put a New Twist on Evolution / Companies / BioTech
Michael A. Robinson writes: Man-made proteins. You may have never heard of them, but you will.
They are set to become huge change agents in the high-tech world of the very near future.
Some of you may have already heard the recent news that doctors believe they can use these compounds to help fight the flu.
Read full article... Read full article...
Wednesday, June 13, 2012
How to Spot the Next Hot Biotech Stock / Companies / BioTech
Keith Fitz-Gerald writes: It's not enough to understand long- term trends, today's investors need to have the ability to move quickly, especially when it comes to biotech stocks.
But here is what you need to know about biotech stocks: none of them are created equal.
Read full article... Read full article...
Wednesday, May 23, 2012
Biotechnology Pushes the Boundaries of Life, It's Like Having a "Fountain of Youth" in a Bottle / Companies / BioTech
Michael A. Robinson writes: Most people will do just about anything to avoid getting a virus.
And yet...There is a microbe that just about everyone will want to invade their bodies.
It's a new "bug" that can actually make you young again.
Read full article... Read full article...
Wednesday, May 16, 2012
How to Ride the Surge in Biotech Mergers & Acquisitions / Companies / BioTech
Don Miller writes: Innovations in biotechnology are evolving at the speed of light.
In fact, astonishing advancements in biotech have transformed the way we practice medicine. Leading-edge biotech products and breakthroughs are literally saving thousands of lives every day.
Read full article... Read full article...